ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Elderly patients"

  • 2021 American Transplant Congress

    Long-Term Outcomes in Older Kidney Transplant Recipients from Older Donors

    E. Cuadrado-Payán, E. Montagud-Marrahi, J. Casals-Urquiza, J. del Risco-Zevallos, D. Cucchiari, P. Ventura-Aguiar, I. Revuelta, G. Piñeiro, N. Esforzado, F. Cofan, J. Ugalde, J. Campistol, F. Oppenheimer, J. Torregrosa, F. Diekmann

    Nephrology and Kidney Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain

    *Purpose: The age of patients referred for kidney transplantation has increased progressively. However, the precise influence of age on hard outcomes after transplantation is controversial*Methods:…
  • 2020 American Transplant Congress

    Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist and Deceased-Donor Kidney Transplant Outcomes among Older Recipients

    J. Ahn1, S. Bae1, K. Lentine2, M. Schnitzler2, G. Hess3, D. Segev1, M. McAdams-DeMarco1

    1Johns Hopkins University, Baltimore, MD, 2Saint Louis University, St. Louis, MO, 3Drexel University, Philadelphia, PA

    *Purpose: Kidney transplantation (KT) has been growing treatment option for older end-stage renal disease patients. Although lymphocyte-depleting agents are considered to be superior than interleukin-2…
  • 2020 American Transplant Congress

    Ehrlichiosis Infection Presenting as Thrombotic Microangiopathy Early after Kidney Transplantation

    W. Hassan1, M. Talwar2, V. Balaraman2, B. Wall1, M. Molnar1

    1Medicine-Nephrology, University of Tennessee Health Science Center, Memphis, TN, 2Department of Surgery, Transplant Surgery, Methodist University Hospital, James D Eason Transplant Institute, Memphis, TN

    *Purpose: Fever of unknown origin and clinical picture of Thrombotic MicroAngiopathy (TMA) are diagnostic challenges in the early period after kidney transplantation. Here we present…
  • 2020 American Transplant Congress

    Impact of Functional Status on Outcomes of Simultaneous Pancreas-Kidney Transplantation: Risks and Opportunities for Patient Benefit

    K. Lentine1, T. Alhamad2, M. Cooper3, Z. Zhang4, K. Woodside5, D. Dadhania6, S. Chang2, D. Axelrod7, M. Schnitzler4, R. Ouseph1, J. Snyder8, B. Kasiske8, R. Parsons9

    1Department of Medicine, Saint Louis University, Saint Louis, MO, 2Washington Univ, Seattle, WA, 3Georgetown Univ, Washington, DC, 4Saint Louis University, Saint Louis, MO, 5Univ of Michigan, Ann Arbor, MI, 6Weill Cornell, New York, NY, 7Univ of Iowa, Iowa City, IA, 8SRTR, Minneapolis, MN, 9Emory, Atlanta, GA

    *Purpose: The impact of functional status on survival among simultaneous pancreas-kidney transplant (SPKT) candidates and recipients is not well described.*Methods: We examined national Scientific Registry…
  • 2020 American Transplant Congress

    80 is the New 60: A Single-Center Outcome Study of Octogenarian Kidney Transplant Recipients

    D. Shankaranarayanan, T. Muthukumar, S. Sultan, A. Watkins, D. Serur, C. Hartono

    Weill Cornell Medicne, New York City, NY

    *Purpose: Kidney transplantation is the treatment of choice for end stage renal disease. However, limited data is available on the outcomes of octogenarian recipients.*Methods: Retrospective…
  • 2020 American Transplant Congress

    Improving Eligibility of Renal Transplants in the Elderly

    L. B. Moraitis1, J. Rogers2, A. Farney1, A. Reeves-Daniel1, G. Orlando1, W. Doares1, S. Kaczmorski1, A. Mena-Gutierrez1, C. Jay1, R. Stratta1

    1Abdominal Organ Transplant, Wake Forest Baptist Health, Winston-Salem, NC, 2Surgery, Wake Forest Baptist Health, Winston-Salem, NC

    *Purpose: In the recent past, older age was a contraindication to kidney transplantation (KT). New kidney allocation schemes with use of longevity matching, initiation of…
  • 2020 American Transplant Congress

    Managing the Road to Kidney Transplantation in the Elderly

    R. S. Munjal, K. Kalra, A. Cherukuri, D. Jorgensen, S. Verma, P. Sood, R. Mehta, C. Puttarajappa, S. Hariharan, C. Wu

    Nephrology, UPMC, Pittsburgh, PA

    *Purpose: We hypothesize that careful patient selection and waitlist management minimizes the impact of advanced recipient age on kidney transplant outcomes.*Methods: A total of 3,521…
  • 2020 American Transplant Congress

    Low-Dose Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients at High Immunologic Risk is Safe and May Prevent Excess Rejection

    E. Sartain1, B. Nettles1, B. Crowther1, P. Klem1, K. Schwarz1, S. Davis2

    1University of Colorado Hospital, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO

    *Purpose: Patients aged ≥65 years are a growing segment of kidney transplant recipients (KTRs). Consensus on induction immunosuppression in this population is unclear given higher…
  • 2020 American Transplant Congress

    Outcome of over 65 Years Old ESRD Patients Referred for Pre-Kidney Transplant Evaluation

    A. M. Alabadi1, A. H. Shaqaq1, K. F. Hamawi1, A. A. Alqatari2, M. Alaskar2, B. S. Alsadah2, A. A. Alomran2, K. B. Akkari1

    1Multi Organ Transplant Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia, 2Faculty of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia

    *Purpose: Potential kidney transplant recipients over the age of 65 years of age form a significant proportion of the total referred for kidney transplant evaluation.…
  • 2020 American Transplant Congress

    An Evaluation of Converting Elderly Kidney Transplant Recipients from Tacrolimus to LCPT to Limit Neurological Adverse Events and Improve Quality of Life

    A. Reticker, B. Valdepenas, K. Bruno, D. Cikopana, S. Walton, E. Benedetti, I. Tzvetanov, P. West-Thielke

    University of Illinois, Chicago, IL

    *Purpose: Adverse effects (AEs) of tacrolimus significantly reduce recipients’ quality of life (QOL). Given its ability for tremor improvement, this study investigates whether conversion from…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 17
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences